Clinical Trials

NCT04624256 | ACTIVE_NOT_RECRUITING | NA
208 participants

Germline DNA-Based Radiosensitivity Biomarker Influence on Toxicity Following Prostate Radiotherapy, GARUDA Trial

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-07
Start Date:
2020-11-10
Completion:
2027-12-31
Conditions
  • Prostate Adenocarcinoma
  • Stage I Prostate Cancer American Joint Committee on Cancer (AJCC) v8
  • Stage II Prostate Cancer AJCC v8
  • Stage IIA Prostate Cancer AJCC v8
  • Stage IIB Prostate Cancer AJCC v8
  • Stage IIC Prostate Cancer AJCC v8
Interventions
  • PROCEDURE
  • RADIATION
  • OTHER
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page